Cbt Ar Arfid denied as not FDA-approved for this use by Humana?

Humana's specific coverage criteria for cbt ar arfid are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Cites "Not FDA-Approved" for CBT-AR for ARFID — and Why You Can Appeal

CBT-AR (Cognitive Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder) is a psychotherapy protocol, not a drug or medical device. The FDA does not approve psychotherapy protocols — it approves drugs, biologics, and certain devices. A "not FDA-approved" denial applied to a psychotherapy service is almost always a categorization error: the FDA approval framework does not apply to behavioral health talk therapy. This type of denial is among the most straightforward to rebut on appeal.

## Why This Is Appealable

Humana's denial, if it cites the absence of FDA approval for a psychotherapy protocol, misapplies the regulatory framework. Psychotherapy is not subject to FDA approval, and requiring it as a coverage condition for a behavioral health service would represent both a category error and, if applied only to mental health treatments, a potential Mental Health Parity Act violation. The appeal should open by establishing this regulatory distinction clearly and asking Humana to identify what approval pathway it believes applies to talk therapy.

## Federal Appeal Framework

• Internal appeal: File within the deadline on your denial letter. Under ERISA §503 (self-funded) or applicable state law (fully insured), Humana must conduct a full-and-fair review. Request that a behavioral health clinician — not a medical reviewer unfamiliar with psychotherapy — review the appeal.
• External review: Under ACA §2719, this denial is subject to independent external review. The general window is approximately four months from the original denial — use the exact deadline on your denial letter.
• Mental Health Parity: If Humana does not apply an FDA-approval requirement to comparable physical health interventions such as physical therapy protocols or occupational therapy approaches, the same standard may not lawfully be applied to behavioral health treatment.
• Expedited review: Request simultaneously with the internal appeal if clinical urgency exists.

## Documentation to Gather

1. ARFID diagnosis records — DSM-5 diagnosis with functional impairment and clinical severity. 2. Regulatory clarification letter from prescriber — a brief statement from the treating clinician explaining that FDA approval is not a regulatory category that applies to psychotherapy protocols and that CBT-AR is billed under standard CPT codes for covered psychotherapy services. 3. Prescriber medical-necessity letter — addresses the clinical necessity of CBT-AR for ARFID, independent of the FDA-approval issue, and cites relevant professional guideline organizations. 4. Benefit summary review — check the Summary Plan Description or Evidence of Coverage for the specific exclusion language Humana is applying; FDA-approval language in a benefits document may only apply to drugs or devices.

## Criteria-Mapping Structure

Request from Humana the specific policy language invoking FDA approval for this denial. Copy it verbatim. In the adjacent column, establish (1) that the FDA approval framework does not apply to psychotherapy, (2) that the CPT code is a covered psychotherapy service, and (3) that if any approval-equivalent standard applies, CBT-AR meets it through professional guideline endorsement.

## Next Step

Ask Humana in writing: "Please identify the specific FDA approval pathway you require for this psychotherapy service and the policy provision mandating it." The inability to answer that question is the centerpiece of your appeal.